Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,552 across all filing types
Latest filing 2025-04-22 Annual Report
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
The Annual Report for the Financial Year ended 31st December 2024 along with the Notice of the 69th AGM which is scheduled to be held on 15th May 2025 through Video Conferencing facility ....
Annual Report Classification · 100% confidence The document is dated April 22, 2025, and is addressed to stock exchanges referencing the Annual General Meeting (AGM) scheduled for May 15, 2025. It explicitly mentions the "Notice of the 69th Annual General Meeting (AGM) and Integrated Annual Report for Financial Year ended 31st December 2024." The text includes detailed information about the AGM logistics, e-voting dates, dividend payment date, and a comprehensive integrated annual report combining financial, social, environmental, and governance disclosures. The document contains extensive content typical of an annual report, including Chairman's message, business strategy, financial performance, statutory reports, and financial statements. It is not merely an announcement or a brief notice but the full integrated annual report itself. Therefore, the document fits the definition of an Annual Report (10-K). FY 2024
2025-04-22 English
Copy of Newspaper Publication
Regulatory Filings
2025-04-16 English
Please find enclosed copies of the newspaper advertisement related to notice of 69th Annual General Meeting, which will be held on 15th May 2025 through video conferencing/other-audio visual means.
Regulatory Filings
2025-04-16 English
Rumour Verification - Regulation 30(11)
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges clarifying a news article about a supposed sale or licensing of a brand. It explicitly states that the information is incorrect and that the company has no plans to divest or license the brand. The document is short (1590 characters) and serves as a clarification or regulatory announcement rather than a financial report or detailed filing. There is no financial data, no report attached or referenced for publication, and no mention of management changes, voting results, or other specific filings. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and clarifications that do not fit other categories.
2025-04-15 English
The intimation is enclosed.
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges clarifying a news article about a supposed sale or licensing of a brand. It explicitly states that the information is incorrect and that the company has no plans to divest or license the brand. The document is short (1590 characters) and serves as a clarification or regulatory announcement rather than a financial report or detailed filing. There is no financial data, no report attached or referenced for publication, and no mention of management changes, voting results, or other specific report types. This fits best as a Regulatory Filing (RNS), which is a general regulatory announcement or compliance document that does not fit other categories.
2025-04-15 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, provided by the Registrar and Share Transfer Agent (RTA) for the period ended 31st March 2025. It is a confirmation certificate related to dematerialisation of securities and compliance with SEBI regulations. The document is short (3277 characters) and primarily serves as a regulatory compliance certificate rather than a financial report or announcement of financial results. It does not contain financial statements, management discussion, or detailed financial data. It is not an announcement of a report but a certificate confirming regulatory compliance. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such regulatory compliance documents that do not fit other specific categories.
2025-04-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.